J. Goldman & Co’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-106,080	Closed	-$7.6M	–	624
2023 Q4	$7.6M	Buy	+106,080	New	+$6.1M	0.42%	100
2023 Q3	–	Sell	-55,595	Closed	-$3.52M	–	592
2023 Q2	$3.52M	Buy	+55,595	New	+$3.46M	0.2%	168
2022 Q1	–	Sell	-7,585	Closed	-$397K	–	517
2021 Q4	$397K	Sell	7,585 -17,057	-69%	-$717K	0.04%	296
2021 Q3	$919K	Sell	24,642 -41,590	-63%	-$1.45M	0.08%	248
2021 Q2	$2.7M	Sell	66,232 -63,800	-49%	-$2.36M	0.17%	200
2021 Q1	$4.41M	Buy	130,032 +706	+0.5%	+$24.5K	0.27%	167
2020 Q4	$4.11M	Buy	+129,326	New	+$3.4M	0.32%	130
2018 Q1	–	Sell	-249,274	Closed	-$3.61M	–	499
2017 Q4	$3.61M	Buy	249,274 +138,374	+125%	+$2.14M	0.34%	139
2017 Q3	$1.75M	Buy	110,900 +26,700	+32%	+$392K	0.16%	204
2017 Q2	$1.05M	Buy	+84,200	New	+$976K	0.11%	212
2016 Q4	–	Sell	-25,000	Closed	-$381K	–	457
2016 Q3	$381K	Buy	+25,000	New	+$1.01M	0.04%	272